Gelatin methacryloyl and Laponite bioink for 3D bioprinted organotypic tumor modeling
Biofabrication · 01.10.2023 · 15 (4) · 045005
DOI: 10.1088/1758-5090/ace0db ↗Kurz gefasst
Fachartikel in der Zeitschrift Biofabrication, online erschienen am 20.07.2023. Verfasst von Natan Roberto de Barros und 20 weiteren Autor:innen. Beteiligte Einrichtung: Terasaki Institute for Biomedical Innovation (TIBI), 1018 Westwood Blvd, Los Angeles, CA 90024, United States of America. Hauptthemen laut MEDLINE: Bioprinting, Neoplasms. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NHLBI NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
Three-dimensional (3D) in vitro tumor models that can capture the pathophysiology of human tumors are essential for cancer biology and drug development. However, simulating the tumor microenvironment is still challenging because it consists of a heterogeneous mixture of various cellular components and biological factors. In this regard, current extracellular matrix (ECM)-mimicking hydrogels used in tumor tissue engineering lack physical interactions that can keep biological factors released by encapsulated cells within the hydrogel and improve paracrine interactions. Here, we developed a nanoengineered ion-covalent cross-linkable bioink to construct 3D bioprinted organotypic tumor models. The bioink was designed to implement the tumor ECM by creating an interpenetrating network composed of gelatin methacryloyl (GelMA), a light cross-linkable polymer, and synthetic nanosilicate (Laponite) that exhibits a unique ionic charge to improve retention of biological factors released by the encapsulated cells and assist in paracrine signals. The physical properties related to printability were evaluated to analyze the effect of Laponite hydrogel on bioink. Low GelMA (5%) with high Laponite (2.5%–3.5%) composite hydrogels and high GelMA (10%) with low Laponite (1.0%–2.0%) composite hydrogels showed acceptable mechanical properties for 3D printing. However, a low GelMA composite hydrogel with a high Laponite content could not provide acceptable cell viability. Fluorescent cell labeling studies showed that as the proportion of Laponite increased, the cells became more aggregated to form larger 3D tumor structures. Reverse transcription-polymerase chain reaction (RT-qPCR) and western blot experiments showed that an increase in the Laponite ratio induces upregulation of growth factor and tissue remodeling-related genes and proteins in tumor cells. In contrast, cell cycle and proliferation-related genes were downregulated. On the other hand, concerning fibroblasts, the increase in the Laponite ratio indicated an overall upregulation of the mesenchymal phenotype-related genes and proteins. Our study may provide a rationale for using Laponite-based hydrogels in 3D cancer modeling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Terasaki Institute for Biomedical Innovation (TIBI), 1018 Westwood Blvd, Los Angeles, CA 90024, United States of America.
- Autonomy Research Center for STEAHM (ARCS), California State University, Northridge, CA 91324, United States of America.
- Department of Biology, California State University, Northridge, CA 91330, United States of America.
- METU Center of Excellence in Biomaterials and Tissue Engineering, Middle East Technical University, Ankara 06800, Turkey.
- Department of Biomedical Engineering, Wake Forest Institute for Regenerative Medicine, Winston-Salem, NC 27101, United States of America.
- Department of Biology, University of California, Irvine, CA 92697, United States of America.
ORCID-Profile: Natan Roberto de Barros, Jonathan Kelber, Ali Khademhosseini, Han-Jun Kim, Bingbing Li
Förderung
- NCI NIH HHS
- NHLBI NIH HHS
- NIDDK NIH HHS
- NIGMS NIH HHS
- National Aeronautics and Space Administration
- Foundation for the National Institutes of Health
- National Science Foundation
- U.S. Department of Defense
Zitieren
APA
de Barros, N. R., Gomez, A., Ermis, M., Falcone, N., Haghniaz, R., Young, P., Gao, Y., Aquino, A. F., Li, S., Niu, S., Chen, R., Huang, S., Zhu, Y., Eliahoo, P., Sun, A., Khorsandi, D., Kim, J., Kelber, J., Khademhosseini, A., …, & Li, B. (2023). Gelatin methacryloyl and Laponite bioink for 3D bioprinted organotypic tumor modeling. Biofabrication, 15(4), 045005. https://doi.org/10.1088/1758-5090/ace0db
Vancouver
de Barros NR, Gomez A, Ermis M, Falcone N, Haghniaz R, Young P, et al. Gelatin methacryloyl and Laponite bioink for 3D bioprinted organotypic tumor modeling. Biofabrication. 2023;15(4):045005. doi:10.1088/1758-5090/ace0db
BibTeX
@article{deBarros2023,
author = {de Barros, Natan Roberto and Gomez, Alejandro and Ermis, Menekse and Falcone, Natashya and Haghniaz, Reihaneh and Young, Patric and Gao, Yaqi and Aquino, Albert-Fred and Li, Siyuan and Niu, Siyi and Chen, RunRun and Huang, Shuyi and Zhu, Yangzhi and Eliahoo, Payam and Sun, Arthur and Khorsandi, Danial and Kim, Jinjoo and Kelber, Jonathan and Khademhosseini, Ali and Kim, Han-Jun and Li, Bingbing},
title = {Gelatin methacryloyl and Laponite bioink for 3D bioprinted organotypic tumor modeling},
journal = {Biofabrication},
year = {2023},
volume = {15},
number = {4},
pages = {045005},
doi = {10.1088/1758-5090/ace0db}
}
EUVIMED